Keyphrases
Tumor Necrosis Factor-α
100%
Clinical Outcomes
100%
Monocyte Subsets
100%
ST-elevation Myocardial Infarction (STEMI)
100%
CCR2
42%
A-level
28%
CD14+
28%
CD16
28%
CD14+CD16+
28%
Mon1
28%
Adverse Cardiac Events
28%
Inflammatory Response
14%
Monocytes
14%
Flow Cytometry
14%
Plasma Parameters
14%
Enzyme-linked Immunosorbent Assay (ELISA)
14%
Acute Phase
14%
Peripheral Blood Monocytes
14%
Atherosclerotic Plaque
14%
CD14
14%
Paired T-test
14%
Inflammatory Macrophages
14%
Day 14
14%
Blood Samples
14%
Mann-Whitney Test
14%
Circulating Monocytes
14%
Spearman Correlation
14%
Percutaneous Revascularization
14%
Myocardial Infarction Patients
14%
Monocytosis
14%
Monocyte Count
14%
Scarce Information
14%
New Diagnosis
14%
Poor Clinical Outcomes
14%
Heart Disease Diagnosis
14%
Nursing and Health Professions
Tumor Necrosis Factor
100%
Clinical Outcome
100%
ST Segment Elevation Myocardial Infarction
100%
Major Adverse Cardiac Event
28%
Enzyme Linked Immunosorbent Assay
14%
Student T Test
14%
Inflammation
14%
Blood Level
14%
Revascularization
14%
Congestive Heart Failure
14%
Rank Sum Test
14%
Monocyte Count
14%
Heart Death
14%
Flow Cytometry
14%
Monocytosis
14%
Immunology and Microbiology
Tumor Necrosis Factor Alpha
100%
CD14
57%
CD16
57%
CCR2
42%
Inflammation Response
14%
Macrophage
14%
Enzyme-Linked Immunosorbent Assay
14%
Cytokine
14%
Blood Level
14%
Revascularization
14%
Monocyte Count
14%